Literature DB >> 21246668

Individual voxel-based subtype prediction can differentiate progressive supranuclear palsy from idiopathic Parkinson syndrome and healthy controls.

Niels K Focke1, Gunther Helms, Sebstian Scheewe, Pia M Pantel, Cornelius G Bachmann, Peter Dechent, Jens Ebentheuer, Alexander Mohr, Walter Paulus, Claudia Trenkwalder.   

Abstract

Voxel-based morphometry (VBM) shows a differentiated pattern in patients with atypical Parkinson syndrome but so far has had little impact in individual cases. It is desirable to translate VBM findings into clinical practice and individual classification. To this end, we examined whether a support vector machine (SVM) can provide useful accuracies for the differential diagnosis. We acquired a volumetric 3D T1-weighted MRI of 21 patients with idiopathic Parkinson syndrome (IPS), 11 multiple systems atrophy (MSA-P) and 10 progressive supranuclear palsy (PSP), and 22 healthy controls. Images were segmented, normalized, and compared at group level with SPM8 in a classical VBM design. Next, a SVM analysis was performed on an individual basis with leave-one-out cross-validation. VBM showed a strong white matter loss in the mesencephalon of patients with PSP, a putaminal grey matter loss in MSA, and a cerebellar grey matter loss in patients with PSP compared with IPS. The SVM allowed for an individual classification in PSP versus IPS with up to 96.8% accuracy with 90% sensitivity and 100% specificity. In MSA versus IPS, an accuracy of 71.9% was achieved; sensitivity, however, was low with 36.4%. Patients with IPS could not be differentiated from controls. In summary, a voxel-based SVM analysis allows for a reliable classification of individual cases in PSP that can be directly clinically useful. For patients with MSA and IPS, further developments like quantitative MRI are needed.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21246668      PMCID: PMC6870106          DOI: 10.1002/hbm.21161

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  35 in total

1.  Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy.

Authors:  M Warmuth-Metz; M Naumann; I Csoti; L Solymosi
Journal:  Arch Neurol       Date:  2001-07

2.  A fast diffeomorphic image registration algorithm.

Authors:  John Ashburner
Journal:  Neuroimage       Date:  2007-07-18       Impact factor: 6.556

Review 3.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.

Authors:  I Litvan; Y Agid; D Calne; G Campbell; B Dubois; R C Duvoisin; C G Goetz; L I Golbe; J Grafman; J H Growdon; M Hallett; J Jankovic; N P Quinn; E Tolosa; D S Zee
Journal:  Neurology       Date:  1996-07       Impact factor: 9.910

4.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

5.  Voxel-based morphometry in autopsy proven PSP and CBD.

Authors:  Keith A Josephs; Jennifer L Whitwell; Dennis W Dickson; Bradley F Boeve; David S Knopman; Ronald C Petersen; Joseph E Parisi; Clifford R Jack
Journal:  Neurobiol Aging       Date:  2006-11-13       Impact factor: 4.673

6.  MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.

Authors:  Aldo Quattrone; Giuseppe Nicoletti; Demetrio Messina; Francesco Fera; Francesca Condino; Pierfrancesco Pugliese; Pierluigi Lanza; Paolo Barone; Letterio Morgante; Mario Zappia; Umberto Aguglia; Olivier Gallo
Journal:  Radiology       Date:  2007-11-08       Impact factor: 11.105

Review 7.  Transcranial sonography in movement disorders.

Authors:  Daniela Berg; Jana Godau; Uwe Walter
Journal:  Lancet Neurol       Date:  2008-11       Impact factor: 44.182

8.  Investigating the predictive value of whole-brain structural MR scans in autism: a pattern classification approach.

Authors:  Christine Ecker; Vanessa Rocha-Rego; Patrick Johnston; Janaina Mourao-Miranda; Andre Marquand; Eileen M Daly; Michael J Brammer; Clodagh Murphy; Declan G Murphy
Journal:  Neuroimage       Date:  2009-08-14       Impact factor: 6.556

9.  Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.

Authors:  Emma J Burton; Ian G McKeith; David J Burn; E David Williams; John T O'Brien
Journal:  Brain       Date:  2004-01-28       Impact factor: 13.501

10.  Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy.

Authors:  C Brenneis; K Seppi; M Schocke; T Benke; G K Wenning; W Poewe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

View more
  43 in total

1.  Improved Automatic Morphology-Based Classification of Parkinson's Disease and Progressive Supranuclear Palsy.

Authors:  Aron S Talai; Zahinoor Ismail; Jan Sedlacik; Kai Boelmans; Nils D Forkert
Journal:  Clin Neuroradiol       Date:  2018-09-14       Impact factor: 3.649

Review 2.  Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy.

Authors:  Keita Sakurai; Aya M Tokumaru; Keigo Shimoji; Shigeo Murayama; Kazutomi Kanemaru; Satoru Morimoto; Ikuko Aiba; Motoo Nakagawa; Yoshiyuki Ozawa; Masashi Shimohira; Noriyuki Matsukawa; Yoshio Hashizume; Yuta Shibamoto
Journal:  Neuroradiology       Date:  2017-04-06       Impact factor: 2.804

3.  MRI volumetric morphometry in vascular parkinsonism.

Authors:  Vincent Dunet; Jeremy Deverdun; Celine Charroud; Emmanuelle Le Bars; Francois Molino; Sophie Menjot de Champfleur; Florence Maury; Mahmoud Charif; Xavier Ayrignac; Pierre Labauge; Giovanni Castelnovo; Frederic Pinna; Alain Bonafe; Christian Geny; Nicolas Menjot de Champfleur
Journal:  J Neurol       Date:  2017-07-01       Impact factor: 4.849

4.  Combined Diffusion Tensor Imaging and Apparent Transverse Relaxation Rate Differentiate Parkinson Disease and Atypical Parkinsonism.

Authors:  G Du; M M Lewis; S Kanekar; N W Sterling; L He; L Kong; R Li; X Huang
Journal:  AJNR Am J Neuroradiol       Date:  2017-03-31       Impact factor: 3.825

Review 5.  Magnetic resonance imaging for the diagnosis of Parkinson's disease.

Authors:  Beatrice Heim; Florian Krismer; Roberto De Marzi; Klaus Seppi
Journal:  J Neural Transm (Vienna)       Date:  2017-04-04       Impact factor: 3.575

6.  Multivariate radiomics models based on 18F-FDG hybrid PET/MRI for distinguishing between Parkinson's disease and multiple system atrophy.

Authors:  Xuehan Hu; Xun Sun; Fan Hu; Fang Liu; Weiwei Ruan; Tingfan Wu; Rui An; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-04-07       Impact factor: 9.236

7.  The topography of brain damage at different stages of Parkinson's disease.

Authors:  Federica Agosta; Elisa Canu; Tanja Stojković; Michela Pievani; Aleksandra Tomić; Lidia Sarro; Nataša Dragašević; Massimiliano Copetti; Giancarlo Comi; Vladimir S Kostić; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2012-04-24       Impact factor: 5.038

Review 8.  The utility of neuroimaging in the differential diagnosis of parkinsonian syndromes.

Authors:  Florian Holtbernd; David Eidelberg
Journal:  Semin Neurol       Date:  2014-06-25       Impact factor: 3.420

9.  Joint feature-sample selection and robust diagnosis of Parkinson's disease from MRI data.

Authors:  Ehsan Adeli; Feng Shi; Le An; Chong-Yaw Wee; Guorong Wu; Tao Wang; Dinggang Shen
Journal:  Neuroimage       Date:  2016-06-10       Impact factor: 6.556

10.  Free-water imaging in Parkinson's disease and atypical parkinsonism.

Authors:  Peggy J Planetta; Edward Ofori; Ofer Pasternak; Roxana G Burciu; Priyank Shukla; Jesse C DeSimone; Michael S Okun; Nikolaus R McFarland; David E Vaillancourt
Journal:  Brain       Date:  2015-12-24       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.